Characterization of the inflammatory response during acute and post-acute phases after severe burn

Shock

Volumn 30, Issue 5, 2008, Pages 503-507

  Gauglitz, Gerd G ^a,b   Song, Juquan ^a,b   Herndon, David N ^a,b   Finnerty, Celeste C ^a,b   Boehning, Darren ^b   Barral, José M ^b   Jeschke, Marc G ^a,b,c  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

Burn; CINC; Cytokines; IL 6; Inflammation

Indexed keywords

CYTOKINE; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR; VASCULOTROPIN;

ACUTE PHASE RESPONSE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; BURN; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HYPERMETABOLISM; INFECTION; INFLAMMATION; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; NEUTROPHIL; NONHUMAN; RAT; SEPSIS; THERMAL INJURY;

ANIMALS; BURNS; CHEMOKINE CCL2; CHEMOKINE CXCL1; CHEMOKINES, CXC; ENZYME-LINKED IMMUNOSORBENT ASSAY; INFLAMMATION; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-6; INTERLEUKIN-8; MALE; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 55949123388     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e31816e3373     Document Type: Article

References (44)

1. Nyhlen K, Gautam C, Andersson R, Srinivas U: Modulation of cytokine-induced production of IL-8 in vitro by interferons and glucocorticosteroids. Inflammation 28(2):77-88, 2004.
2. de Bandt JP, Chollet-Martin S, Hernvann A, Lioret N, du Roure LD, Lim SK, Vaubourdolle M, Guechot J, Saizy R, Giboudeau J, et al.: Cytokine response to burn injury: relationship with protein metabolism. J Trauma 36(5):624-628, 1994.
3. Ueyama M, Maruyama I, Osame M, Sawada Y: Marked increase in plasma interleukin-6 in burn patients. J Lab Clin Med 120(5):693-698, 1992.
4. Endo S, Inada K, Yamada Y, Kasai T, Takakuwa T, Nakae H, Kikuchi M, Hoshi S, Suzuki M, Yamashita H, et al.: Plasma tumour necrosis factor-alpha (TNF-alpha) levels in patients with burns. Burns 19(2):124-127, 1993.
5. Finnerty CC, Herndon DN, Przkora R, Pereira CT, Oliveira HM, Queiroz DM, Rocha AM, Jeschke MG: Cytokine expression profile over time in severely burned pediatric patients. Shock 26(1):13-19, 2006.
6. Frost RA, Lang CH, Gelato MC: Transient exposure of human myoblasts to tumor necrosis factor-alpha inhibits serum and insulin-like growth factor-I stimulated protein synthesis. Endocrinology 138(10):4153-4159, 1997.
7. Van den Berghe G, de Zegher F, Veldhuis JD, Wouters P, Awouters M, Verbruggen W, Schetz M, Verwaest C, Lauwers P, Bouillon R, et al.: The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH- releasing peptide-2 infusion. J Clin Endocrinol Metab 82(2):590-599, 1997.
8. Wray CJ, Mammen JM, Hasselgren PO: Catabolic response to stress and potential benefits of nutrition support. Nutrition 18(11-12):971-977, 2002.
9. Herndon DN: Total Burn Care. New York, NY; WB Saunders, 2002.
10. Takala J, Ruokonen E, Webster NR, Nielsen MS, Zandstra DF, Vundelinckx G, Hinds CJ: Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 341(11):785-792, 1999.
11. Parker SJ, Watkins PE: Experimental models of gram-negative sepsis. Br J Surg 88(1):22-30, 2001.
12. Cugini D, Azzollini N, Gagliardini E, Cassis P, Bertini R, Colotta F, Noris M, Remuzzi G, Benigni A: Inhibition of the chemokine receptor CXCR2 prevents kidney graft function deterioration due to ischemia/reperfusion. Kidney Int 67(5):1753-1761, 2005.
13. Ramos CD, Heluy-Neto NE, Ribeiro RA, Ferreira SH, Cunha FQ: Neutrophil migration induced by IL-8-activated mast cells is mediated by CINC-1. Cytokine 21(5):214-223, 2003.
14. Nakagawa H, Ikesue A, Kato H, Debuchi H, Watanabe K, Tsurufuji S, Naganawa M, Mitamura M: Changes in the levels of rat interleukin 8/CINC and gelatinase in the exudate of carrageenin-induced inflammation in rats. J Pharmacobiodyn 15(9):461-466, 1992.
15. Watanabe K, Koizumi F, Kurashige Y, Tsurufuji S, Nakagawa H: Rat CINC, a member of the interleukin-8 family, is a neutrophil-specific chemoattractant in vivo. Exp Mol Pathol 55(1):30-37, 1991.
16. Herndon DN, Wilmore DW, Mason AD Jr: Development and analysis of a small animal model simulating the human postburn hypermetabolic response. J Surg Res 25(5):394-403, 1978.
17. Yeh FL, Shen HD, Fang RH: Deficient transforming growth factor beta and interleukin-10 responses contribute to the septic death of burned patients. Burns 28(7):631-637, 2002.
18. Jeschke MG, Einspanier R, Klein D, Jauch KW: Insulin attenuates the systemic inflammatory response to thermal trauma. Mol Med 8(8):443-450, 2002.
19. Davis KA, Santaniello JM, He LK, Muthu K, Sen S, Jones SB, Gamelli RL, Shankar R: Burn injury and pulmonary sepsis: development of a clinically relevant model. J Trauma 56(2):272-278, 2004.
20. Vindenes HA, Ulvestad E, Bjerknes R: Concentrations of cytokines in plasma of patients with large burns: their relation to time after injury, burn size, inflammatory variables, infection, and outcome. Eur J Surg 164(9):647-656, 1998.
21. Kaplan E, Dinarello CA, Gelfand JA: Interleukin-1 and the response to injury. Immunol Res 8(2):118-129, 1989.
22. Goodman RB, Pugin J, Lee JS, Matthay MA: Cytokine-mediated inflammation in acute lung injury. Cytokine Growth Factor Rev 14(6):523-535, 2003.
23. Greenberger MJ, Kunkel SL, Strieter RM, Lukacs NW, Bramson J, Gauldie J, Graham FL, Hitt M, Danforth JM, Standiford TJ: IL-12 gene therapy protects mice in lethal Klebsiella pneumonia. J Immunol 157(7):3006-3012, 1996.
24. van der Poll T, Keogh CV, Guirao X, Buurman WA, Kopf M, Lowry SF: Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia. J Infect Dis 176(2):439-444, 1997.
25. Vindenes H, Ulvestad E, Bjerknes R: Increased levels of circulating interleukin-8 in patients with large burns: relation to burn size and sepsis. J Trauma 39(4):635-640, 1995.
26. Hata J, Aoki K, Mitsuhashi H, Uno H: Change in location of cytokine-induced neutrophil chemoattractants (CINCs) in pulmonary silicosis. Exp Mol Pathol 75(1):68-73, 2003.
27. Mitsuhashi H, Hata J, Asano S, Kishimoto T: Appearance of cytokine-induced neutrophil chemoattractant isoforms and immunolocalization of them in lipopolysaccharide-induced acute lung inflammation in rats. Inflamm Res 48(11):588-593, 1999.
28. Li X, Kovacs EJ, Schwacha MG, Chaudry IH, Choudhry MA: Acute alcohol intoxication increases interleukin-18-mediated neutrophil infiltration and lung inflammation following bum injury in rats. Am J Physiol Lung Cell Mol Physiol 292(5):L1193-L1201, 2007.
29. Yamada Y, Endo S, Inada K: Plasma cytokine levels in patients with severe burn injury - with reference to the relationship between infection and prognosis. Burns 22(8):587-593, 1996.
30. Taniguchi T, Koido Y, Aiboshi J, Yamashita T, Suzaki S, Kurokawa A: The ratio of interleukin-6 to interleukin-10 correlates with severity in patients with chest and abdominal trauma. Am J Emerg Med 17(6):548-551, 1999.
31. Biffl WL, Moore EE, Moore FA, Peterson VM: Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation? Ann Surg 224(5): 647-664, 1996.
32. Hack CE, Hart M, van Schijndel RJ, Eerenberg AJ, Nuijens JH, Thijs LG, Aarden LA: Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infect Immun 60(7):2835-2842, 1992.
33. Cruickshank AM, Fraser WD, Burns HJ, Van Damme J, Shenkin A: Response of serum interleukin-6 in patients undergoing elective surgery of varying severity. Clin Sci (Lond) 79:161-165, 1990.
34. Plackett TP, Colantoni A, Heinrich SA, Messingham KA, Gamelli RL, Kovacs EJ: The early acute phase response after burn injury in mice. J Burn Care Res 28(1):167-172, 2007.
35. Steensberg A, Fischer CP, Keller C, Moller K, Pedersen BK: IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. Am J Physiol Endocrinol Metab 285(2):E433-E437, 2003.
36. Schneider CP, Schwacha MG, Chaudry IH: The role of interleukin-10 in the regulation of the systemic inflammatory response following trauma-hemorrhage. Biochim Biophys Acta 1689(1):22-32, 2004.
37. Lyons A, Kelly JL, Rodrick ML, Mannick JA, Lederer JA: Major injury induces increased production of interleukin-10 by cells of the immune system with a negative impact on resistance to infection. Ann Surg 226(4):450-460, 1997.
38. Luster AD: Chemokines - chemotactic cytokines that mediate inflammation. N Engl J Med 338(7):436-445, 1998.
39. Kim CH, Broxmeyer HE: Chemokines: signal lamps for trafficking of T and B cells for development and effector function. J Leukoc Biol 65(1):6-15, 1999.
40. Sell H, Eckel J: Monocyte chemotactic protein-1 and its role in insulin resistance. Curr Opin Lipidol 18(3):258-262, 2007.
41. Infanger M, Faramarzi S, Grosse J, Kurth E, Ulbrich C, Bauer J, Wehland M, Kreutz R, Kossmehl P, Paul M, et al.: Expression of vascular endothelial growth factor and receptor tyrosine kinases in cardiac ischemia/reperfusion injury. Cardiovasc Pathol 16(5):291-299, 2007.
42. Khalil AA, Hall JC, Aziz FA, Price P: Tumour necrosis factor: implications for surgical patients. ANZ J Surg 76(11):1010-1016, 2006.
43. Pereira C, Murphy K, Jeschke M, Herndon DN: Post burn muscle wasting and the effects of treatments. Int J Biochem Cell Biol 37(10):1948-1961, 2005.
44. Przkora R, Barrow RE, Jeschke MG, Suman OE, Celis M, Sanford AP, Chinkes DL, Mlcak RP, Herndon DN: Body composition changes with time in pediatric bum patients. J Trauma 60(5):968-971, 2006.